Length polymorphism in Heme Oxygenase-1 and risk of CKD among patients with coronary artery disease

Journal of the American Society of Nephrology

Volumn 25, Issue 11, 2014, Pages 2669-2677

  Chen, Yu Hsin ^a,b   Kuo, Ko Lin ^c   Hung, Szu Chun ^c   Hsu, Chih Cheng ^d   Chen, Ying Hwa ^a,e   Tarng, Der Cherng ^a,e  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI CITY HOSPITAL   (Taiwan)

^c TAIPEI TZU CHI HOSPITAL   (Taiwan)

^d NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^e TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

GUANOSINE; HEME OXYGENASE 1; THYMIDINE; HMOX1 PROTEIN, HUMAN;

AGED; ARTICLE; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; CORONARY ARTERY DISEASE; CREATININE BLOOD LEVEL; DINUCLEOTIDE REPEAT; FEMALE; GENE FREQUENCY; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT; CHRONIC KIDNEY FAILURE; EPIDEMIOLOGY; FOLLOW UP; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; KAPLAN MEIER METHOD; MIDDLE AGED; PROPORTIONAL HAZARDS MODEL; RISK FACTOR;

AGED; CORONARY ARTERY DISEASE; FEMALE; FOLLOW-UP STUDIES; GENETIC PREDISPOSITION TO DISEASE; HEME OXYGENASE-1; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC; PROPORTIONAL HAZARDS MODELS; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS;

EID: 84904990991     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2013111205     Document Type: Article

References (40)

1. Maines MD: Heme oxygenase: Function, multiplicity, regulatory mechanisms, and clinical applications. FASEB J 2: 2557-2568, 1988
2. Nath KA: Heme oxygenase-1: A provenance for cytoprotective pathways in the kidney and other tissues. Kidney Int 70: 432-443, 2006
3. Juan SH, Lee TS, Tseng KW, Liou JY, Shyue SK, Wu KK, Chau LY: Adenovirus-mediated heme oxygenase-1 gene transfer inhibits the development of atherosclerosis in apolipoprotein E-deficient mice. Circulation 104: 1519-1525, 2001
4. Tamura T, Kondo T, Ogawa K, Fukunaga K, Ohkohchi N: Protective effect of heme oxygenase-1 on hepatic ischemia-reperfusion injury through inhibition of platelet adhesion to the sinusoids. J Gastroenterol Hepatol 28: 700-706, 2013
5. Otterbein LE, Kolls JK, Mantell LL, Cook JL, Alam J, Choi AM: Exogenous administration of heme oxygenase-1 by gene transfer provides protection against hyperoxia-induced lung injury. J Clin Invest 103: 1047-1054, 1999
6. Laniado-Schwartzman M, Abraham NG, Conners M, Dunn MW, Levere RD, Kappas A: Heme oxygenase induction with attenuation of experimentally induced corneal inflammation. Biochem Pharmacol 53: 1069-1075, 1997
7. Kutty RK, Kutty G, Rodriguez IR, Chader GJ, Wiggert B: Chromosomal localization of the human heme oxygenase genes: Heme oxygenase-1 (HMOX1) maps to chromosome 22q12 and heme oxygenase-2 (HMOX2)maps to chromosome 16p13.3. Genomics 20: 513-516, 1994
8. Exner M, Schillinger M, Minar E, Mlekusch W, Schlerka G, Haumer M, Mannhalter C, Wagner O: Heme oxygenase-1 gene promoter microsatellite polymorphism is associated with restenosis after percutaneous transluminal angioplasty. J Endovasc Ther 8: 433-440, 2001
9. Chen YH, Lin SJ, Lin MW, Tsai HL, Kuo SS, Chen JW, Charng MJ, Wu TC, Chen LC, Ding YA, Pan WH, Jou YS, Chau LY: Microsatellite polymorphism in promoter of heme oxygenase-1 gene is associated with susceptibility to coronary artery disease in type 2 diabetic patients. Hum Genet 111: 1-8, 2002
10. Kaneda H, Ohno M, Taguchi J, Togo M, Hashimoto H, Ogasawara K, Aizawa T, Ishizaka N, Nagai R: Heme oxygenase-1 gene promoter polymorphism is associated with coronary artery disease in Japanese patients with coronary risk factors. Arterioscler Thromb Vasc Biol 22: 1680-1685, 2002
11. Schillinger M, Exner M, Minar E, Mlekusch W, Müllner M, Mannhalter C, Bach FH, Wagner O: Heme oxygenase-1 genotype and restenosis after balloon angioplasty: A novel vascular protective factor. J Am Coll Cardiol 43: 950-957, 2004
12. Chen YH, Chau LY, Lin MW, Chen LC, Yo MH, Chen JW, Lin SJ: Heme oxygenase-1 gene promotormicrosatellite polymorphismis associated with angiographic restenosis after coronary stenting. Eur Heart J 25: 39-47, 2004
13. Dick P, Schillinger M, Minar E, Mlekusch W, Amighi J, Sabeti S, Schlager O, Raith M, Endler G, Mannhalter C, Wagner O, Exner M: Haemoxygenase-1 genotype and cardiovascular adverse events in patients with peripheral artery disease. Eur J Clin Invest 35: 731-737, 2005
14. Wu MM, Chiou HY, Chen CL, Wang YH, Hsieh YC, Lien LM, Lee TC, Chen CJ: GT-repeat polymorphism in the heme oxygenase-1 gene promoter is associated with cardiovascular mortality risk in an arsenic-exposed population in northeastern Taiwan. Toxicol Appl Pharmacol 248: 226-233, 2010
15. Wu MM, Chiou HY, Lee TC, Chen CL, Hsu LI, Wang YH, Huang WL, Hsieh YC, Yang TY, Lee CY, Yip PK, Wang CH, Hsueh YM, Chen CJ: GT-repeat polymorphismin the heme oxygenase-1 gene promoter and the risk of carotid atherosclerosis related to arsenic exposure. J Biomed Sci 17: 70, 2010
16. Wu MM, Chiou HY, Chen CL, Hsu LI, Lien LM, Wang CH, Hsieh YC, Wang YH, Hsueh YM, Lee TC, Cheng WF, Chen CJ: Association of heme oxygenase-1 GT-repeat polymorphism with blood pressure phenotypes and its relevance to future cardiovascular mortality risk: An observation based on arsenic-exposed individuals. Atherosclerosis 219: 704-708, 2011
17. Chen YH, Hung SC, Tarng DC: Length polymorphismin heme oxygenase-1 and cardiovascular events and mortality in hemodialysis patients. Clin J Am Soc Nephrol 8: 1756-1763, 2013
18. Courtney AE, Maxwell AP: Heme oxygenase 1: Does it have a role in renal cytoprotection? Am J Kidney Dis 51: 678-690, 2008
19. Elsayed EF, Tighiouart H, Griffith J, Kurth T, Levey AS, Salem D, Sarnak MJ, Weiner DE: Cardiovascular disease and subsequent kidney disease. Arch Intern Med 167: 1130-1136, 2007
20. Kiyosue A, Hirata Y, Ando J, Fujita H, Morita T, Takahashi M, Nagata D, Kohro T, Imai Y, Nagai R: Relationship between renal dysfunction and severity of coronary artery disease in Japanese patients. Circ J 74: 786-791, 2010
21. Hsu TW, Kuo KL, Hung SC, Huang PH, Chen JW, Tarng DC: Progression of kidney disease in non-diabetic patients with coronary artery disease: Predictive role of circulating matrix metalloproteinase-2, -3, and -9. PLoS ONE 8: e70132, 2013
22. Agarwal A, Nick HS: Renal response to tissue injury: Lessons from heme oxygenase-1 Gene Ablation and expression. J Am Soc Nephrol 11: 965-973, 2000
23. Kim JH, Yang JI, Jung MH, Hwa JS, Kang KR, Park DJ, Roh GS, Cho GJ, Choi WS, Chang SH: Heme oxygenase-1 protects rat kidney from ureteral obstruction via an antiapoptotic pathway. J Am Soc Nephrol 17: 1373-1381, 2006
24. Kie JH, Kapturczak MH, Traylor A, Agarwal A, Hill-Kapturczak N: Heme oxygenase-1 deficiency promotes epithelial-mesenchymal transition and renal fibrosis. J Am Soc Nephrol 19: 1681-1691, 2008
25. Desbuards N, Hyvelin JM, Machet MC, Eder V, Garrigue MA, Halimi JM, Antier D: Heme oxygenase-1 inducer hemin attenuates the progression of remnant kidney model. Nephron, Exp Nephrol 113: e35-e44, 2009
26. Correa-Costa M, Semedo P, Monteiro AP, Silva RC, Pereira RL, Gonc¸alves GM, Marques GD, Cenedeze MA, Faleiros AC, Keller AC, Shimizu MH, Seguro AC, Reis MA, Pacheco-Silva A, Câmara NO: Induction of heme oxygenase-1 can halt and even reverse renal tubuleinterstitial fibrosis. PLoS ONE 5: e14298, 2010
27. Lüblinghoff N, Winkler K, Winkelmann BR, Seelhorst U, Wellnitz B, Boehm BO, März W, Hoffmann MM: Genetic variants of the promoter of the heme oxygenase-1 gene and their influence on cardiovascular disease (the Ludwigshafen Risk and Cardiovascular Health study). BMC Med Genet 10: 36, 2009
28. Pritchard JK, Rosenberg NA: Use of unlinked genetic markers to detect population stratification in association studies. Am J Hum Genet 65: 220-228, 1999
29. Goodman AI, Chander PN, Rezzani R, Schwartzman ML, Regan RF, Rodella L, Turkseven S, Lianos EA, Dennery PA, Abraham NG: Heme oxygenase-2 deficiency contributes to diabetes-mediated increase in superoxide anion and renal dysfunction. J Am Soc Nephrol 17: 1073-1081, 2006
30. Nath KA, Grande JP, Farrugia G, Croatt AJ, Belcher JD, Hebbel RP, Vercellotti GM, Katusic ZS: Age sensitizes the kidney to heme protein-induced acute kidney injury. Am J Physiol Renal Physiol 304: F317-F325, 2013
31. Stocker R, Yamamoto Y, McDonagh AF, Glazer AN, Ames BN: Bilirubin is an antioxidant of possible physiological importance. Science 235: 1043-1046, 1987
32. Willis D, Moore AR, Frederick R, Willoughby DA: Heme oxygenase: A novel target for themodulation of the inflammatory response. Nat Med 2: 87-90, 1996
33. Chen YH, Chau LY, Chen JW, Lin SJ: Serum bilirubin and ferritin levels link heme oxygenase-1 gene promoter polymorphism and susceptibility to coronary artery disease in diabetic patients. Diabetes Care 31: 1615-1620, 2008
34. Zarjou A, Bolisetty S, Joseph R, Traylor A, Apostolov EO, Arosio P, Balla J, Verlander J, Darshan D, Kuhn LC, Agarwal A: Proximal tubule H-ferritin mediates iron trafficking in acute kidney injury. J Clin Invest 123: 4423-4434, 2013
35. Katan MB: Apolipoprotein E isoforms, serum cholesterol, and cancer. Lancet 1: 507-508, 1986
36. Courtney AE, McNamee PT, Heggarty S, Middleton D, Maxwell AP: Association of functional haem oxygenase-1 gene promoter polymorphism with polycystic kidney disease and IgA nephropathy. Nephrol Dial Transplant 23: 608-611, 2008
37. Chin HJ, Cho HJ, Lee TW, Na KY, Yoon HJ, Chae DW, Kim S, Jeon US, Do JY, Park JW, Yoon KW, Shin YT, Lee KW, Na KR, Cha DR, Kang YS; Progressive REnal disease and Medical Informatics and gEnomics Research (PREMIER) members: The heme oxygenase-1 genotype is a risk factor to renal impairment of IgA nephropathy at diagnosis, which is a strong predictor of mortality. J Korean Med Sci 24[Suppl]: S30-S37, 2009
38. Concato J, Shah N, Horwitz RI: Randomized, controlled trials, observational studies, and the hierarchy of research designs. N Engl JMed 342: 1887-1892, 2000
39. Nielsen F, Mikkelsen BB, Nielsen JB, Andersen HR, Grandjean P: Plasma malondialdehyde as biomarker for oxidative stress: Reference interval and effects of life-style factors. Clin Chem 43: 1209-1214, 1997
40. Kimpara T, Takeda A, Watanabe K, Itoyama Y, Ikawa S, Watanabe M, Arai H, Sasaki H, Higuchi S, Okita N, Takase S, Saito H, Takahashi K, Shibahara S:Microsatellite polymorphismin the human heme oxygenase-1 gene promoter and its application in association studies with Alzheimer and Parkinson disease. Hum Genet 100: 145-147, 1997